Tag: BTK

Philips announces positive two-year data from TOBA II BTK clinical trial

Royal Philips recently announced positive two-year results from the TOBA (Tack optimized balloon angioplasty) II below-the-knee (BTK) clinical trial. The data show the Philips Tack endovascular...

Innovation: ISET audience hears what’s on the horizon for CLTI patients

“I am going to give you reasons to be excited about your critical limb practice,” Peter Schneider, MD, professor of vascular and endovascular surgery...

MicroStent to treat PAD below the knee receives FDA breakthrough device...

Micro Medical Solutions (MMS) recently revealed Food and Drug Administration (FDA) breakthrough device designation for its MicroStent vascular stent. This novel technology is designed...

FDA panel recommends against premarket approval of Lutonix 014 DCB for...

A Food and Drug Administration (FDA) advisory panel has recommended against premarket approval of BD’s Lutonix 014 drug-coated balloon (DCB) for use in below-the-knee (BTK) arteries....

Data show potential of Limflow system to improve outcomes for no-option...

“Deep vein arterialization is safe and technically feasible,” Peter Schneider, MD, a professor in the division vascular and endovascular surgery at the University of...

First US commercial use of Tack Endovascular System in BTK arteries...

Intact Vascular has announced the first commercial use of its Tack Endovascular System (4F) in multiple sites across the United States. Notably the first Food...